EVEROLIMUS FACILITATES CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE LIVER TRANSPLANT PATIENTS WITH RENAL IMPAIRMENT

被引:0
|
作者
De Simone, Paolo [1 ]
Nevens, Frederik [2 ]
Metselaar, Harold. L. [3 ]
Sterneck, Martina [4 ]
Dumortier, Jerome [5 ]
Duvoux, Christophe [6 ]
Boudjema, Karim [4 ]
Le Treut, Yves-Patrice [7 ]
机构
[1] Liver Transplant Unit, Pisa, Italy
[2] Univ Hosp Gasthuisberg, Louvain, Belgium
[3] Erasmus MC, Rotterdam, Netherlands
[4] Univ Hosp Hamburg Eppendorf, Hamburg, Germany
[5] Hop Edouard Herriot, Lyon, France
[6] Hop Henri Mondor, F-94010 Creteil, France
[7] Hop Conception, Marseille, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S225 / S225
页数:1
相关论文
共 50 条
  • [1] CALCINEURIN INHIBITOR WITHDRAWAL IN THE PRESENCE OF EVEROLIMUS IS FEASIBLE IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS
    Fischer, Lutz
    De Simone, Paolo
    Nevens, Frederik
    Metselaat, Herold J.
    Dumortier, Jerome
    Duvoux, Christophe
    Boudjema, Karim
    Le Treut, Yves Patrice
    Sterneck, Martina R.
    HEPATOLOGY, 2008, 48 (04) : 566A - 566A
  • [2] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients
    Budde, K.
    Zeier, M.
    Haller, H.
    Arns, W.
    Kramer, S.
    Vogel, E. M.
    Pietruck, F.
    Reinke, P.
    Rath, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 504 - 504
  • [3] Multicenter, randomized trial of conversion to everolimus with calcineurin inhibitor minimization or discontinuation in liver transplant patients with renal impairment
    Nevens, Frederic
    Sterneck, Martina
    Metselaar, Herald
    Dumortier, Jerome
    Giostra, Emiliono
    Boudjema, Karim
    Varo, Evaristo
    de Simone, Paolo
    HEPATOLOGY, 2007, 46 (04) : 486A - 487A
  • [4] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 714 - 715
  • [5] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    TRANSPLANTATION, 2014, 98 : 714 - 715
  • [6] RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS ONE YEAR AFTER CONVERSION
    Reinke, P.
    Rath, T.
    Budde, K.
    Arns, W.
    Kramer, S.
    Vogel, E. -M.
    Pietruck, F.
    Haller, H.
    Sommerer, C.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 48 - 48
  • [7] Mycophenolate mofetil in liver transplant patients with calcineurin-inhibitor-induced renal impairment
    Ko, Hin Hin
    Greanya, Erica
    Lee, Tim K.
    Steinbrecher, Urs P.
    Erb, Siegfried R.
    Yoshida, Eric M.
    ANNALS OF HEPATOLOGY, 2008, 7 (04) : 376 - 380
  • [8] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 3 Year Data of the APOLLO Trial
    Rath, T.
    Budde, K.
    Sommerer, C.
    Haller, H.
    Suwelack, B.
    May, C.
    Paulus, E. -M
    Witzke, O.
    Reinke, P.
    TRANSPLANTATION, 2012, 94 (10) : 994 - 994
  • [9] TWO YEAR DATA OF THE APOLLO TRIAL: RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS
    Reinke, P.
    Haller, H.
    Rath, T.
    Arns, W.
    Paulus, E. -M.
    Scheidl, S.
    Witzke, O.
    Sommerer, C.
    Budde, K.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 50
  • [10] Everolimus as a Calcineurin Inhibitor-Sparing Immunosuppressive Agent in Lung Transplant Recipients With Renal Impairment
    Yo, Shaun
    Coughlan, Tim
    Ivulich, Steve
    Paul, Eldho
    Snell, Gregory
    Menahem, Solomon
    CHEST, 2017, 152 (04) : 1098A - 1098A